Skip to main content

Eucapnic voluntary hyperpnea challenge can support management of exercise-induced bronchoconstriction in elite swimmers

Gowers, William, Evans, Guy, Carre, Jane, Ashman, Matt, Jackson, Anna, Hopker, James G., Dickinson, John W. (2021) Eucapnic voluntary hyperpnea challenge can support management of exercise-induced bronchoconstriction in elite swimmers. Translational Sports Medicine, . pp. 1-10. E-ISSN 2573-8488. (doi:10.1002/tsm2.258) (KAR id:89030)

PDF Publisher pdf
Language: English
Download (595kB) Preview
[thumbnail of Gowers et al EVH and GB Swimming 2021.pdf]
Preview
This file may not be suitable for users of assistive technology.
Request an accessible format
Official URL
https://dx.doi.org/10.1002/tsm2.258

Abstract

Introduction: This study investigated the use of eucapnic voluntary hyperpnea (EVH) to monitor efficacy of pharmacological therapy in elite swimmers with exercise-induced bronchoconstriction (EIB). Secondly, it evaluated the long-term test-retest repeatability of EVH in this population.

Methods: Twenty-seven elite international swimmers were included in this retrospective analysis of comprehensive respiratory assessments. Following an initial “withheld-therapy” assessment, athletes with EIB had been prescribed appropriate pharmacological therapy and returned twelve months later for a follow-up assessment to monitor EIB protection afforded by treatment. EIB-negative athletes had returned to confirm initial diagnosis, as were still reporting persistent respiratory symptoms. Athletes were retrospectively grouped into either “Therapy Adherent Group” (n = 12) or “Repeatability Group” (discontinued therapy at follow-up or EIB-negative, n = 15).

Results: Greatest fall in forced expiratory volume in 1 second (ΔFEV1max) was significantly lower following therapy adherence (−11.8 ± 3.8%) compared to initial assessment (−24.0 ± 11.3%; P < .01). “Repeatability Group” ΔFEV1max did not differ significantly between initial assessment (−13.1 ± 4.5%) and follow-up (−12.3 ± 5.6%; P = .32), and showed good agreement (0.6%; −5.9%, 7.1%).

Conclusion: A follow-up assessment utilizing EVH is useful in the management of EIB and shows good test-retest repeatability over twelve months in elite swimmers who discontinue treatment or are EIB-negative.

Item Type: Article
DOI/Identification number: 10.1002/tsm2.258
Subjects: R Medicine > RC Internal medicine > RC1200 Sports medicine
Divisions: Divisions > Division of Natural Sciences > Sport and Exercise Sciences
Signature Themes: Future Human
Depositing User: John Dickinson
Date Deposited: 05 Jul 2021 11:11 UTC
Last Modified: 06 Jul 2021 09:09 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/89030 (The current URI for this page, for reference purposes)
Hopker, James G.: https://orcid.org/0000-0002-4786-7037
Dickinson, John W.: https://orcid.org/0000-0002-1824-7402
  • Depositors only (login required):